Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 18,700 shares at $77.13 ($1.5M) on 2026-01-07, disclosed to the SEC on 2026-01-09.
Open-market sale of $1.5M APGE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.13 | 2,954 | $228K | 15.7% |
| 2 | $77.90 | 14,820 | $1.2M | 79.3% |
| 3 | $79.04 | 826 | $65K | 4.5% |
| 4 | $80.06 | 100 | $8K | 0.6% |
| Total | $77.84 avg | 18,700 | $1.5M | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |